Search Results: PARP

• For Researchers

Future leaders and a lifetime in drug development: our research prizes

Last week we had the pleasure of awarding our Research Prizes to five exceptional researchers at our annual prizegiving ceremony at the NCRI Conference. Last week we had the pleasure of awarding our Research Prizes to five exceptional researchers at our annual prizegiving ceremony at the NCRI Conference.

16 November 2016

• Personal Stories

How your support is helping us beat breast cancer – Margaret’s story

The year is 2016, Breast Cancer Awareness Month is upon us, and right now, 8 in 10 women diagnosed with breast cancer will survive their disease for 10 years or more. The year is 2016, Breast Cancer Awareness Month is upon us, and right now, 8 in 10 women diagnosed with breast cancer will survive their disease for 10 years or more.

1 October 2016

• Science & Technology

CRT and SV Life Sciences form Artios Pharma to focus on DNA damage response

Cancer Research Technology (CRT) and SV Life Sciences have today announced the launch of Artios Pharma. Cancer Research Technology (CRT) and SV Life Sciences have today announced the launch of Artios Pharma.

21 September 2016

• Health & Medicine

Crashing cancer’s backup system – our progress so far

Research by our scientists played a major part in the development of a promising new class of cancer drugs. So where are we now in this research journey? Research by our scientists played a major part in the development of a promising new class of cancer drugs. So where are we now in this research journey?

12 September 2016

• Health & Medicine

Study opens door to targeted treatments for oesophageal cancer

Scientists have discovered that oesophageal cancer can be classified into three different subtypes, paving the way for testing targeted treatments. Scientists have discovered that oesophageal cancer can be classified into three different subtypes, paving the way for testing targeted treatments.

5 September 2016

• Science & Technology

Pancreatic cancer trial to make tumours more sensitive to treatment

Cancer Research UK launches a first-of-its-kind pancreatic cancer clinical trial to make cancer cells more responsive to chemotherapy and radiotherapy. Cancer Research UK launches a first-of-its-kind pancreatic cancer clinical trial to make cancer cells more responsive to chemotherapy and radiotherapy.

29 August 2016

• Science & Technology
• Health & Medicine

All women with ovarian cancer should be offered genetic testing – so why aren’t they?

Recent research has reinforced the need for all women with ovarian cancer to receive genetic testing, but they aren't. We explore why. Recent research has reinforced the need for all women with ovarian cancer to receive genetic testing, but they aren't. We explore why.

17 August 2016

• Science & Technology
• Health & Medicine

Dundee research explains drug resistance in ovarian cancer

Scientists in Dundee have uncovered important information about how ovarian cancer becomes resistant to certain treatments. Scientists in Dundee have uncovered important information about how ovarian cancer becomes resistant to certain treatments.

10 August 2016

• For Researchers

A celebrated career in DNA repair: Tomas Lindahl

We look at how Tomas Lindahl’s discoveries have profoundly changed our understanding of cell response to cytotoxic therapies and the implications of this. We look at how Tomas Lindahl’s discoveries have profoundly changed our understanding of cell response to cytotoxic therapies and the implications of this.

10 August 2016

• Science & Technology
• Health & Medicine

Inherited gene faults could play greater role in advanced prostate cancer than previously thought

Inherited gene faults are more common among men with advanced prostate cancer than in those with localised disease. Inherited gene faults are more common among men with advanced prostate cancer than in those with localised disease.

7 July 2016

• Science & Technology
• Health & Medicine

News digest - drug approval, flexible pressure sensor, pen-sized microscope, engineered molecules and… olive oil?

Cancer drugs approved, a tiny microscope for spotting cancer cells, engineering molecules so cells can ‘sense’ and why some £5 olive oil isn’t worth it. Cancer drugs approved, a tiny microscope for spotting cancer cells, engineering molecules so cells can ‘sense’ and why some £5 olive oil isn’t worth it.

30 January 2016

"Surprised and deeply honoured" - our chief executive receives a knighthood

Our chief executive, Harpal Kumar, has received a knighthood for services to cancer research Our chief executive, Harpal Kumar, has received a knighthood for services to cancer research

30 December 2015